Chargement en cours...
Simvastatin potentiates doxorubicin activity against MCF-7 breast cancer cells
Simvastatin is a low density lipoprotein-lowering drug that is widely used to prevent and treat cardiovascular disease by inhibiting the mevalonate pathway. Simvastatin also exhibits inhibitory effects on a number of types of cancer. In the present study, the effects of simvastatin on the activity o...
Enregistré dans:
| Publié dans: | Oncol Lett |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
D.A. Spandidos
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5661424/ https://ncbi.nlm.nih.gov/pubmed/29113274 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.6783 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|